We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

European Medicines Agency Approves Orphan Medicinal Product Application of DCPrime's AML Vaccine

News   Feb 02, 2012

 
European Medicines Agency Approves Orphan Medicinal Product Application of DCPrime's AML Vaccine
 
 
 

RELATED ARTICLES

Metabolic Vulnerability Could Inspire New Pancreatic Cancer Treatments

News

Researchers have identified a new vulnerability in pancreatic cancer, which may provide a potential strategy for combating one of the most treatment-resistant malignancies.

READ MORE

Vaccine for African Swine Fever Virus Shows Promise

News

Government and academic investigators have developed a vaccine against African swine fever that appears to be far more effective than previously developed vaccines.

READ MORE

Immune Cells Aid Invasion of Brain Tumors

News

A team has analyzed the role of immune cells in the expansion of glioblastoma, a type of aggressive brain tumor.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE